QIAGEN powered by

Webinars and events

Loading Events

« All Events

  • This event has passed.

Making discoveries from public data (GEO, SRA and more) using QIAGEN Ingenuity Pathway Analysis

November 16, 2023 @ 1:00 pm - 2:30 pm

You requested it, and we’re here to deliver. We’re excited to offer you comprehensive training on how to effectively use samplelevel public data and metadata from sources like GEO, SRA, TCGA, GTEx, Blueprint, CCLE and other sources through QIAGEN Ingenuity Pathway Analysis (IPA) and the IPA Analysis Match Explorer feature. Your trainer will walk you through use cases in related to biomarker discovery, drug target investigation, studying survival in custom patient cohorts, multi-gene correlation and more. 
Note: The word “condition” below refers to different diseases, disease subtypes, treatments, cell types, cell lines and more. 

In this training, we’ll cover topics such as: 
• How is a gene of interest expressed across different conditions? 
• Is there a correlation in expression for two genes or biomarkers of user interest for a given condition? 
• For a given condition of interest, can we derive a list of genes (for example, genes specific to a disease, treatment or cell type)? 
• Can we generate custom cohorts of patients (for example, TP53 wt vs mutant or PDCD1 high vs low expression) and then generate survival curves representing those cohorts? Can we generate p-value to see if there is a significant difference? 
• Recent update: Can we detect the expression of a gene in different cell types from singlecell data? 


Date: November 16, 2023
 1:00 pm - 2:30 pm
Register for event
Event Categories:


Virtual – Americas – EST
United States


Discovery, Webinar
Register for event

On-demand Webinars

  • Supercharge your AI in drug discovery with high-quality biomedical data

    If you’re working in pharma or biotech, you likely rely on artificial intelligence (AI) to help you identify new drug targets or plausible biomarkers for disease within large data sets. Yet AI alone isn’t enough. A large proportion of Biomedical data have errors and are unstructured. For AI models to provide reliable insights, the underlying data must be of ‘hig...

  • Scale up NGS bioinformatics analysis throughput with QIAGEN CLC Genomics cloud computing

    Scale your NGS analysis to match your sequencing throughput using our QIAGEN CLC Genomics cloud solution. In this webinar, you’ll learn about the flexible and powerful setup for running your NGS sequence analyses on Amazon Web Services (AWS). You’ll learn how to use QIAGEN CLC Genomics Workbench to customize workflows and send analyses to AWS Batch for execution. ...

  • QIAGEN Biomedical Knowledge Base: Data- and analytics-driven drug discovery

    Biomedical relationships knowledge is now required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many more applications. In this one-hour training, you’ll get an introduction to QIAGEN Biomedical Knowledge Base. You’ll learn how to tackle appli...

  • Part 1: AI-Powered Hereditary Disease Diagnostics: Closing the Gap in Clinical Exome Completeness

    Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic vari...

  • A breakthrough for rare disease: Completing the Clinical exome gap!

    In its latest release, QCI Interpret for Hereditary extends its market-leading content with further advancements in Artificial Intelligence (AI) for enhanced capabilities in clinical exome NGS testing. Now, with the addition of AI-derived literature references for rare disease genes, QCI Interpret provides complete exome coverage, on top of the existing unrivalled man...

  • What’s new in QIAGEN IPA Fall Release 2023?

    Interested in learning about new features and functionalities that have been added to IPA lately? During this webinar, we will highlight the updates from the QIAGEN IPA Fall Release and from previous releases from this year. Topics, amongst others, will be • Newly added findings and pathways • Reactome pathways • Artificial intelligence approves to pathways ...